$6.09
0.325.55%
Últ. Act.: Oct 19, 12:40 PM
$5.96
0.193.29%
Precision BioSciences (DTIL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.68 | $-0.70 | $-0.47 | $-1.45 |
| Actual | $-1.26 | $-0.75 | $1.05 | $-1.84 |
| Surprise | -85.3% | -7.14% | +323.4% | -26.9% |
| Revenue | ||||
| Estimate | $1.8M | $4.8M | $10.4M | $7.7M |
| Actual | $0 | $10.8M | $34.2M | $13000 |
| Surprise | -100.0% | +126.7% | +230.0% | -99.8% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.92 | $-1.03 | $-0.39 | $-0.40 |
| Revenue | ||||
| Consensus | $1.4M | $1.3M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.26 | $-0.68 | -85.3 % |
| Q1 | May 5, 2026 | $-0.75 | $-0.70 | -7.14 % |
| Q4 | Mar 12, 2026 | $1.05 | $-0.47 | 323.4 % |
| Q3 | Nov 3, 2025 | $-1.84 | $-1.45 | -26.9 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $1.78M | -100.0 % |
| Q1 | May 5, 2026 | $10.84M | $4.78M | 126.7 % |
| Q4 | Mar 12, 2026 | $34.20M | $10.37M | 230.0 % |
| Q3 | Nov 3, 2025 | $13.00K | $7.68M | -99.8 % |